Myovant Sciences Ltd. Accounts Receivable
Myovant Sciences Ltd. had Accounts Receivable of $41.02 million as of 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2023-01-26
- 2022-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $41.02M.
- 2022-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $33.76M.
- 2022-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $29.65M.
- 2022-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $23.30M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2022-12-31 | $41.02M 10-Q · filed 2023-01-26 |
| 2022-09-30 | $33.76M 10-Q · filed 2022-10-26 |
| 2022-06-30 | $29.65M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $23.30M 10-Q · filed 2023-01-26 |
| 2021-12-31 | $18.91M 10-Q · filed 2022-01-26 |
| 2021-09-30 | $14.40M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $10.61M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $3.57M 10-K · filed 2022-05-11 |
| 2020-03-31 | $0.00 10-K · filed 2021-05-11 |